[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Phase 1 Recruiting
120 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients
Phase 1 Completed
39 enrolled
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase 1 Completed
54 enrolled
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Phase 1 Completed
230 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
FPA008-003
Phase 1 Completed
313 enrolled 30 charts
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Phase 1 Completed
20 enrolled
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
Phase 1 Terminated
21 enrolled
Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
Phase 1 Completed
92 enrolled
Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors
Phase 1 Completed
28 enrolled
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
Phase 1 Withdrawn
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
33 enrolled
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
Phase 1 Completed
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Phase 1 Completed
NGR-TNF in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
70 enrolled
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Phase 1 Terminated
3 enrolled
SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck
Phase 1 Completed
12 enrolled
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
Phase 1 Completed
25 enrolled